On Thursday, Alpharetta, Georgia headquartered Alimera Sciences Inc.'s stock recorded a trading volume of 171,713 shares and ended the session flat at $1.45. The Company's shares have gained 18.85% in the previous three months. The stock is trading 8.52% below its 50-day moving average. Moreover, shares of Alimera Sciences, which engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the US, Germany, Portugal, and the UK, have a Relative Strength Index (RSI) of 37.16. The free research report on ALIM is available at:
Xianyang, the People's Republic of China headquartered Biostar Pharmaceuticals Inc.'s stock closed the day 1.59% lower at $4.32 and with a total trading volume of 915,674 shares. The Company's shares have advanced 27.43% in the past month, 8.27% in the previous three months, and 54.29% on an YTD basis. The stock is trading 27.04% above its 50-day moving average and 55.97% above its 200-day moving average. Additionally, shares of Biostar Pharmaceuticals, which develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China, have an RSI of 55.70.
On October 12th, 2016, Biostar Pharmaceuticals announced that it entered into a securities purchase agreement with certain institutional investors for the sale of 425,000 shares of common stock in a registered direct offering at the price of $4.50 per share. In addition, warrants to purchase 212,500 shares of its common stock in the aggregate will be issued to the investors. Gross proceeds of the offering, before deducting placement agent fees and other estimated offering expenses payable by the company, are expected to be approximately $1.91 million. The net proceeds from this offering will be used for working capital and other general corporate purposes. The complimentary report on BSPM can be downloaded at:
Shares in Brentwood, Tennessee-based LifePoint Health Inc. recorded a trading volume of 510,302 shares, which was higher than their three months average volume of 499,370 shares. The stock ended yesterday's trading session 1.25% higher at $60.55. The Company's shares have advanced 6.53% in the past month. The stock is trading above its 50-day moving average by 4.67%. Furthermore, shares of LifePoint Health, which through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the US, have an RSI of 61.72.
As per notes filed with the SEC on September 19th, 2016, LifePoint Health announced the appointment of Michael S. Coggin, the company's Senior Vice President and Chief Accounting Officer, on September 6th, 2016, as the Company's Chief Financial Officer, effective September 30th, 2016. Following a successful transition, Mr. Coggin became the company's Executive Vice President and Chief Financial Officer effective September 16th, 2016. Visit us today and download our complete research report on LPNT for free at:
Franklin, Tennessee-based Quorum Health Corp.'s stock finished Thursday's session 0.67% higher at $6.04 with a total trading volume of 211,340 shares. Shares of the Company, which owns and operates hospitals, are trading below their 50-day moving average by 9.90%. The stock has an RSI of 41.87.
On October 3rd, 2016, Quorum Health announced that subsidiaries of the company have signed a definitive agreement to sell 56-bed Barrow Regional Medical Center in Winder, Georgia, and its associated assets, to Northeast Georgia Health System, Inc. The divestiture is expected to close December 31, 2016, subject to customary regulatory approvals and closing conditions. Get free access to your technical report on QHC at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA